| Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Small Cell Lung Carcinoma
|
712 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.790 | 1.000 | 26 | 2002 | 2019 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 13 | 2008 | 2019 | |||||
Colorectal Neoplasms
|
609 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 1.000 | 12 | 2005 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 11 | 2009 | 2019 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2010 | 2018 | |||||
Juvenile Myelomonocytic Leukemia
|
70 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.820 | 1.000 | 10 | 2005 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2009 | 2019 | |||||
ovarian neoplasm
|
757 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 9 | 2005 | 2011 | |||||
Adenocarcinoma
|
168 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.070 | 1.000 | 7 | 2012 | 2020 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 6 | 1987 | 2014 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||
Malignant neoplasm of pancreas
|
277 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2003 | 2019 | |||||
melanoma
|
515 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Pancreatic carcinoma
|
322 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.740 | 1.000 | 4 | 2003 | 2019 | |||||
Rhabdomyosarcoma
|
20 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.040 | 1.000 | 4 | 2010 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 4 | 1987 | 2004 | |||||
Thyroid Neoplasm
|
135 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 1.000 | 4 | 2007 | 2013 | |||||
Brain Neoplasms
|
204 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Immunologic Deficiency Syndromes
|
31 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2005 | 2016 | |||||
Organoid Nevus Phakomatosis
|
9 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.730 | 1.000 | 3 | 2012 | 2019 | |||||
Pancreatic intraepithelial neoplasia
|
11 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||
Precancerous Conditions
|
18 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2010 | 2015 | |||||
Secondary malignant neoplasm of colon and/or rectum
|
68 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Secondary Neoplasm
|
85 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2009 | 2016 |